• Repaglinide may be effective vs. sulfonylurea in older adults with type 2 diabetes

    1 month ago - By Healio

    Lean older adults with type 2 diabetes experienced lower glycated albumin levels and less glucose variability when using repaglinide vs. sulfonylurea, according to study results from researchers in Japan.
    “Analysis of continuous blood glucose monitoring systems to evaluate the glycemic control achieved using has shown that asymptomatic hypoglycemia is common. In addition, are often insufficient to manage postprandial hyperglycemia,” Hideaki Miyoshi, MD, department of rheumatology, endocrinology and nephrology, faculty of medicine at the Graduate
    Read more ...

     

  • Treating Diabetes in Patients With CKD at Kidney Week

    1 month ago - By Medscape

    Clinical trials looking at the safety and efficacy of glucose-lowering agents in patients with chronic kidney disease and diabetes will be center stage at Kidney Week 2018.
    Medscape Medical News
    Read more ...

     

  • Effects of a high-fat diet are reduced with the golden tickseed

    Effects of a high-fat diet are reduced with the golden tickseed

    1 month ago - By Natural News

    Good news for diabetics: A study, published in Chinese Herbal Medicines, revealed that the golden tickseed can be used to treat insulin resistance. The researchers, who were from the Chinese Academy of Medical Sciences and Peking Union Medical College and China Academy of Chinese Medical Sciences, determined the effect of ethyl acetate extract of...
    Read more ...

     

  • New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

    1 month ago - By News Medical

    HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic , are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.
    Read more ...

     

  • Top stories in endocrinology: Linagliptin effective in some patients with type 2 diabetes, inhaled insulin improves glucose control in type 1 diabetes

    1 month ago - By Healio

    Among the top stories in endocrinology this week was a study that found linagliptin was effective and safe in patients with type 2 diabetes that also have kidney disease and CVD, a report that concluded that empagliflozin added to the life expectancy of patients with diabetes and CVD and another study that found that inhaled insulin led to better glucose control in patients with type 1 diabetes.
    Other popular stories included findings that mindfulness might mediate some of the symptoms associated with menopause and new information regarding a possible app for automated insulin delivery
    Read more ...